Welcome to our regularly scheduled break from reality: Reddit drama edition. We’re reading Am I the Asshole? stories so ridiculous, petty, awkward, and chaotic that they deserve a full investigation.

No topic is too small for an opinion—roommates, weddings, work drama, family feuds, bad dates, borrowed clothes, group chats, and people who clearly should have kept certain thoughts to themselves. Grab a drink, pick a side, and get ready to judge strangers with us.

Ozempic, Wegovy, Mounjaro, Zepbound—GLP-1 medications have gone from diabetes treatment to one of the biggest conversations in weight loss, wellness, celebrity culture, and social media. But as demand rises, so do the questions: Are these medications being treated like a quick fix? Who are they actually for? And what happens when the hype moves faster than the conversation about risk?

In this episode, we unpack the GLP-1 boom, the difference between medically guided treatment and trend-driven use, and the lawsuits alleging serious complications such as severe gastrointestinal injuries. We also talk about the side effects and warnings patients should understand, why individualized medical care matters, and why “everyone is taking it” is never a good reason to start a prescription medication.

Pink costs more—but why? This episode dives into the pink tax, gendered pricing, and the surprising ways companies may charge more for products marketed to women and other specific demographics. We compare everyday essentials, unpack the marketing behind the markup, and talk about how to spot when you’re paying extra for the label instead of the product.